Liver Disease Clinical Trials

Showing 201-220 of 690 trials

HELIO Liver Test Performance Study in China (HEPATIC)

NCT05053412

De-identified whole blood and serum samples are collected for the purpose of evaluating the performance (sensitivity/specificity) of the HelioLiver Test for the detection of hepatocellular carcinoma (HCC).

Hepatocellular Carcinoma and Liver Disease

Helio Genomics1,556 participantsStarted Sep 2021

Beijing, Beijing Municipality, China • Beijing, China

COMPLETEDPHASE1/PHASE2

Normothermic Liver Preservation Trial

NCT03089840

This trial is to assess the safety and efficacy of normothermic machine perfusion (NMP) as an organ preservation method prior to transplantation using the OrganOx metra™ device.

End Stage Liver DiseaseLiver Diseases

University of Alberta106 participantsStarted Feb 2017

Edmonton, Alberta, Canada

ENROLLING_BY_INVITATION

Investigating Myosteatosis in Steatotic Liver Diseases

NCT06514300

Steatotic liver diseases (SLD) are the most common chronic liver diseases worldwide. SLD are defined by an excessive liver lipid content (steatosis) of more than 5% of the total liver weight and includes 3 clinical entities : metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-related liver disease (ALD) and a mixed entity combining the two settings referred as MetALD. SLD are associated to extra-hepatic complications such as cardiovascular diseases, insulin resistance or muscle changes. Among the latter, myosteatosis, defined by an excessive muscle fat content, has been reported as a muscle change in MASLD occuring even in non-cirrhotic stages. Investigators will explore these muscle changes in SLD patients according to the severity of the underneath liver disease.

Cliniques universitaires Saint-Luc- Université Catholique de Louvain100 participantsStarted Jun 2020

Brussels, Belgium

HELIO Liver Test Performance Study in China (HEPATIC)

Normothermic Liver Preservation Trial

Investigating Myosteatosis in Steatotic Liver Diseases

Related Searches

Targeting the Skeletal Muscle to Treat Metabolic Dysfunction-associated Steatotic Liver Disease

Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver Disease

Evaluation of the Inter-center Variability of the Measurement of Thrombin Generation by the ST Genesia System

Biomarkers for the Detection of Heavy Alcohol Use in Patients With and Without Liver Disease

To Evaluate the Beneficial Effect of Probiotics on NAFLD Patients and the Role of Gut Microbiota Modulation

TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC

Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Non-Alcoholic Fatty Liver Disease (PARADISE-NAFLD)

Bridge to HOPE: Hypothermic Oxygenated Perfusion Versus Cold Storage Prior to Liver Transplantation

Effect of High Intensity Exercise Rehabilitation on Liver Function and Insulin Sensitivity in Patients With MASLD

Autologous Bone Marrow Mononuclear Stem Cell for Children Suffering From Liver Cirrhosis Due to Biliary Atresia

Effects of Almonds in Glucose-intolerant Adults (AGAMEMNON)

Early Liver Disease Breath Detection

Influence of a Mediterranean Diet Combined With a Physical Activity Intervention, on NAFLD and Inflammation Parameters.

A Prospective, Randomized, Placebo-Controlled Pilot Study to Characterize the Intestinal Microbiome and to Evaluate the Safety and Fecal Microbiome Changes Following Administration of Lyophilized PRIM-DJ2727 or Placebo Given Orally in Subjects With Nonalcoholic Fatty Liver Disease

Effectiveness of Bariatric Surgery for NAFLD/NASH

Assessment of Microorganisms and Host Response In Liver Diseases

Freiburg TIPS Registry